DocDollars

Nuvasive, Inc.

CA · United States · Reporting entity ID 100000010655

Total reported 2019–2025
$102.9M
#91 of 2,960 reporting companies — 0.1% of all reported industry payments
$97.8M in general payments across 63,693 records, plus $5.08M in research funding across 1,544 records.

How it breaks down

General payments $97,818,821
Research funding $5,075,745

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Nuvasive, Inc. reported $102.9M to US doctors and teaching hospitals from 2019 to 2025, ranking #91 of 2,960 reporting companies. 5% of that was research funding and 95% general payments such as consulting, speaking, food and travel. 63,693 general payment records and 1,544 research records were filed.

Common questions about Nuvasive, Inc.

How much has Nuvasive, Inc. paid US doctors?

Nuvasive, Inc. reported $102,894,567 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $97,818,821 in general payments, $5,075,745 in research funding.

How does Nuvasive, Inc. rank among drug and device companies?

It ranks #91 of 2,960 reporting entities by total reported value, about 0.1% of all industry payments in the dataset.

Does a payment from Nuvasive, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.